CivatlasThe Civilization Atlas

Company

OSIVAX

  • Biotech
Headquarters:
Paris

Description

Osivax develops vaccines using its oligoDOM self‑assembling nanoparticle platform to elicit potent T‑cell responses and broaden protection for people against mutating pathogens.